| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Section of Endocrinology (J.B., G.A.I., T.U.), Rikshospitalet-Radiumhospitalet Medical Center, University of Oslo, N-0027 Oslo, Norway; Departments of Surgery (S.J.) and Endocrinology (C.F., T.R.), Sahlgrenska Hospital, S-416 85 Gothenburg, Sweden; Department of Endocrine Surgery (C.L.M.), Copenhagen University Hospital, DK-2100 Rigshospitalet, Denmark; Department of Surgery (J.N.), Karolinska University Hospital Solna, SE-171 76 Stockholm, Sweden; Department of Surgery (E.L.), Akademiska Hospital, SE-751 85 Uppsala, Sweden; Section of Endocrinology (O.T.), Department of Medicine, Södersjukhuset, SE-118 83 Stockholm, Sweden; Departments of Surgery (J.-E.V.) and Endocrinology (S.A.), Haukeland University Hospital and Institute of Medicine, University of Bergen, N-5021 Bergen, Norway; Department of Medicine (M.B.), St. Olavs Hospital, University of Trondheim, 7006 Trondheim, Norway; and Department of Metabolism and Endocrinology (B.F.), Karolinska University Hospital, SE-141 86 Huddinge, Sweden
Address all correspondence and requests for reprints to: Jens Bollerslev, M.D., D.Med.Sci., Section of Endocrinology, Department of Medicine, National University Hospital, N-0027 Oslo, Norway. E-mail: jens.bollerslev{at}medisin.uio.no.
Context: The clinical presentation of primary hyperparathyroidism (pHPT) has changed during the last half century, and the diagnosis is now more often made by chance in patients with no specific symptoms.
Objective: The present study is a randomized, controlled trial that investigates the effects of parathyroidectomy or medical observation in mild asymptomatic pHPT on morbidity and quality of life (QoL).
Design/Setting/Patients: A total of 191 patients (26 men) with asymptomatic pHPT [mean age 64.2 ± 7.4 (SD) yr] were recruited in the study and randomized to medical observation (serum calcium level 2.69 ± 0.08 mmol/liter) or surgery (2.70 ± 0.08 mmol/liter). We here report baseline and 1 (n = 119) and 2 yr data (n = 99) on those who had completed the follow-up visits by the end of the inclusion period.
Results: At baseline, the patients had significantly lower QoL (SF-36) and more psychological symptoms, compared with age- and sex-matched healthy subjects. The two groups were similar at baseline, and no clinically significant changes in these parameters were seen during the observation time. Calcium and PTH normalized after surgery. The areal bone mineral density increased in the group randomized to operation, whereas the bone mineral density remained stable in the medical observation group. No change in kidney function (creatinine) or blood pressure was observed longitudinally or between the groups.
Conclusions: Asymptomatic patients with mild pHPT have decreased QoL and more psychological symptoms than normal controls. No benefit of operative treatment, compared with medical observation, was found on these measures so far.
This article has been cited by other articles:
![]() |
M. D. Walker, D. J. McMahon, W. B. Inabnet, R. M. Lazar, I. Brown, S. Vardy, F. Cosman, and S. J. Silverberg Neuropsychological Features in Primary Hyperparathyroidism: A Prospective Study J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 1951 - 1958. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Silverberg, E. M. Lewiecki, L. Mosekilde, M. Peacock, and M. R. Rubin Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 351 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Udelsman, J. L. Pasieka, C. Sturgeon, J. E. M. Young, and O. H. Clark Surgery for Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 366 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Khan, A. Grey, and D. Shoback Medical Management of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 373 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. El-Hajj Fuleihan Hyperparathyroidism: Time to Reconsider Current Clinical Decision Paradigms? J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3302 - 3304. [Full Text] [PDF] |
||||
![]() |
M. R. Rubin, J. P. Bilezikian, D. J. McMahon, T. Jacobs, E. Shane, E. Siris, J. Udesky, and S. J. Silverberg The Natural History of Primary Hyperparathyroidism with or without Parathyroid Surgery after 15 Years J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3462 - 3470. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Adler, R. S. Sippel, and H. Chen The Influence of Surgical Approach on Quality of Life After Parathyroid Surgery Ann. Surg. Oncol., June 1, 2008; 15(6): 1559 - 1565. [Abstract] [Full Text] [PDF] |
||||
![]() |
S M Webb, X Badia, M J Barahona, A Colao, C J Strasburger, A Tabarin, M O van Aken, R Pivonello, G Stalla, S W J Lamberts, et al. Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire Eur. J. Endocrinol., May 1, 2008; 158(5): 623 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Siilin, J. Rastad, O. Ljunggren, and E. Lundgren Disturbances of Calcium Homeostasis Consistent with Mild Primary Hyperparathyroidism in Premenopausal Women and Associated Morbidity J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 47 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ambrogini, F. Cetani, L. Cianferotti, E. Vignali, C. Banti, G. Viccica, A. Oppo, P. Miccoli, P. Berti, J. P. Bilezikian, et al. Surgery or Surveillance for Mild Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized Clinical Trial J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3114 - 3121. [Abstract] [Full Text] [PDF] |
||||
![]() |
Observation vs. Surgery for Asymptomatic Primary Hyperparathyroidism Journal Watch (General), May 22, 2007; 2007(522): 1 - 1. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |